Biotech - Press Releases

Date	Title	Company
03-Apr-2020	InsurTech Holdings, Life Epigenetics, and YouSurance are rebranding to FOXO BioScience	FOXO BioScience
03-Apr-2020	Leica Biosystems Receives FDA's Enforcement Discretion For Use Of Aperio ImageScope DX Viewing Software For Remote Diagnosis During COVID-19 Emergency	Leica Biosystems
03-Apr-2020	Gracell Announces China MNPA Acceptance of Investigational New Drug Application for GC007g Cell Therapy for CD19 Positive Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia	Gracell
03-Apr-2020	NMI® at 52.5%; March 2020 Non-Manufacturing ISM® Report On Business®	Institute for Supply Management
03-Apr-2020	Coeliac UK launches appeal to keep support going for thousands with autoimmune disease	National charity Coeliac UK
03-Apr-2020	The Alliance for Regenerative Medicine to Host FDA Representatives for Webinar on Clinical Trial Guidance During COVID-19 on April 10, 2020	The Alliance for Regenerative Medicine
03-Apr-2020	Availability of the Pre-quarterly Results Communication	Sanofi
03-Apr-2020	Dupixent® (dupilumab) Phase 3 data show significant improvement in severe atopic dermatitis for children aged 6 to 11 years	Sanofi
03-Apr-2020	Mistura Informatics Donates Medicines Information Software to Tackle COVID-19	Mistura Informatics
03-Apr-2020	Axon Presented Positive Phase II Trial Results of AADvac1 at AAT-AD/PD 2020	AXON Neuroscience SE
03-Apr-2020	Scientists on Standby portal launched to support the recruitment of overflow resource for the testing of COVID-19	Scientists on Standby
03-Apr-2020	Dupixent® (dupilumab) Phase 3 Data at Revolutionizing Atopic Dermatitis Conference Show Significant Improvement in Severe Atopic Dermatitis for Children Aged 6 to 11 Years	Regeneron Pharmaceuticals, Inc.
02-Apr-2020	Windtree Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Key Business Updates	Windtree Therapeutics, Inc.
02-Apr-2020	Kodiak Sciences Appoints Charles Bancroft to Board of Directors	Kodiak Sciences Inc.
02-Apr-2020	New Publication Describes Mechanism of Action for Tb4 in Corneal Wound Healing and Regeneration	RegeneRx Biopharmaceuticals, Inc.
02-Apr-2020	FDA ACCEPTS MESOBLAST’S BIOLOGICS LICENCE APPLICATION FOR RYONCIL™ AND AGREES TO PRIORITY REVIEW	Mesoblast Limited
02-Apr-2020	Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™	Emergent BioSolutions
02-Apr-2020	Generation Bio and Vir Biotechnology to Collaborate on Research to Leverage Scalable Non-Viral Gene Therapy Platform for Durable Production of Monoclonal Antibodies Against Coronavirus That Causes COVID-19	Generation Bio
02-Apr-2020	INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-associated Vulvar Dysplasia	INOVIO Pharmaceuticals, Inc
02-Apr-2020	REGENERON ANNOUNCES AMERICAN COLLEGE OF CARDIOLOGY PRESENTATION OF POSITIVE PHASE 3 EVINACUMAB RESULTS IN PATIENTS WITH SEVERE INHERITED FORM OF HIGH CHOLESTEROL	Regeneron Pharmaceuticals, Inc.